Callahan Advisors LLC increased its position in Danaher Corporation (NYSE:DHR) by 2.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,835 shares of the conglomerate’s stock after buying an additional 450 shares during the period. Callahan Advisors LLC’s holdings in Danaher Corporation were worth $1,758,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of DHR. Lee Danner & Bass Inc. boosted its stake in Danaher Corporation by 0.4% during the 1st quarter. Lee Danner & Bass Inc. now owns 2,635 shares of the conglomerate’s stock valued at $225,000 after purchasing an additional 10 shares during the last quarter. Norway Savings Bank boosted its stake in Danaher Corporation by 0.4% during the 2nd quarter. Norway Savings Bank now owns 2,238 shares of the conglomerate’s stock valued at $189,000 after purchasing an additional 10 shares during the last quarter. First Financial Corp IN boosted its stake in Danaher Corporation by 0.8% during the 2nd quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock valued at $230,000 after purchasing an additional 21 shares during the last quarter. Guardian Life Insurance Co. of America boosted its stake in Danaher Corporation by 1.0% during the 1st quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock valued at $202,000 after purchasing an additional 24 shares during the last quarter. Finally, Assetmark Inc. boosted its stake in Danaher Corporation by 0.5% during the 1st quarter. Assetmark Inc. now owns 6,622 shares of the conglomerate’s stock valued at $566,000 after purchasing an additional 30 shares during the last quarter. Institutional investors own 75.75% of the company’s stock.
A number of equities analysts have issued reports on DHR shares. Credit Suisse Group reiterated a “buy” rating and set a $93.00 price target on shares of Danaher Corporation in a research note on Wednesday, May 24th. Janney Montgomery Scott downgraded Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. BidaskClub downgraded Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Thursday, June 15th. Zacks Investment Research downgraded Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Monday, June 19th. Finally, Deutsche Bank AG reiterated a “buy” rating and set a $97.00 price target on shares of Danaher Corporation in a research note on Wednesday, June 21st. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $92.72.
In related news, insider William King sold 7,458 shares of the firm’s stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the sale, the insider now owns 18,245 shares in the company, valued at $1,513,787.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the firm’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the sale, the insider now owns 155,520 shares in the company, valued at approximately $12,718,425.60. The disclosure for this sale can be found here. In the last quarter, insiders have sold 71,496 shares of company stock worth $5,916,223. Corporate insiders own 12.20% of the company’s stock.
Shares of Danaher Corporation (NYSE DHR) opened at 87.27 on Wednesday. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01. The company has a 50 day moving average of $81.99 and a 200-day moving average of $84.14. The company has a market cap of $60.63 billion, a PE ratio of 27.86 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The firm had revenue of $4.51 billion for the quarter, compared to analysts’ expectations of $4.50 billion. During the same quarter in the prior year, the company posted $0.90 earnings per share. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. Equities research analysts anticipate that Danaher Corporation will post $3.95 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be issued a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.64%. Danaher Corporation’s payout ratio is 17.83%.
ILLEGAL ACTIVITY WARNING: This article was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at https://www.tickerreport.com/banking-finance/2887800/callahan-advisors-llc-raises-stake-in-danaher-corporation-dhr.html.
Danaher Corporation Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.